Bringing TPG’s scale and expertise to drive Innovation in life sciences
TPG’s Life Sciences Innovation (LSI) fund invests in novel therapeutics as well as digital health, medical devices, diagnostics, and tech-enabled services. We leverage our core team’s and TPG’s broad expertise in healthcare to focus on supporting companies that are meaningfully improving patients’ outcomes. LSI invests across therapeutic areas and stages from company creation to IPO. We pride ourselves on being great partners, with a differentiated ability to scale our investment based on companies’ needs.